Locus-specific HLA matching and induction therapy in simultaneous pancreas–kidney transplantation: a national UK cohort study
Transplant International · 2026
DOI: 10.3389/ti.2026.16427 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Transplant International, 2026. Verfasst von Abdullah K Malik und 18 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Transplantation, Freeman Hospital, Newcastle upon Tyne, United Kingdom. Hauptthemen laut MEDLINE: Pancreas Transplantation, Kidney Transplantation, HLA Antigens. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, National Institute for Health and Care Research.
Abstract (Originalsprache)
The impact of HLA mismatch and induction therapy in simultaneous pancreas-kidney transplantation on outcomes remains incompletely defined. We conducted a retrospective cohort study of 1705 SPK recipients transplanted in the UK between 2007 and 2019. Using national transplant registry data, we analysed the impact of locus-specific HLA mismatch and induction therapy (Alemtuzumab vs. Basiliximab) on pancreas graft survival primarily. Kidney graft and patient survival were also analysed as secondary outcomes. Multivariable Cox proportional hazards models were adjusted for donor, recipient, and transplant variables. Pancreas graft survival at 1- and 10-year post-transplant was estimated to be 88.6% and 72.7%, respectively. Kidney graft and patient survival at 10 years were 76.7% and 75.3%. In adjusted analyses, donor age, cold ischaemic time, and HLA-DQ mismatch were significantly associated with pancreas graft loss. No significant survival difference was seen between Alemtuzumab and Basiliximab induction therapy. Induction therapy and HLA-mismatch status were not associated with pancreas graft outcome in this large registry study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Transplantation, Freeman Hospital, Newcastle upon Tyne, United Kingdom.
- NIHR Blood and Transplant Research Unit, Newcastle University and Cambridge University, Newcastle upon Tyne, United Kingdom.
- Newcastle Fibrosis Research Group, Newcastle University, Newcastle upon Tyne, United Kingdom.
- NHS Blood and Transplant, Bristol, United Kingdom.
- Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
- Imperial College Healthcare NHS Trust, London, United Kingdom.
Förderung
- Medical Research Council
- National Institute for Health and Care Research
Zitieren
APA
Malik, A. K., Banks, J., Counter, C., Simmonds, L., Tingle, S. J., Sinha, S., Muthasamy, A., Sutherland, A., Casey, J., Drage, M., van Dellen, D., Callaghan, C. J., Elker, D., Manas, D. M., Pettigrew, G. J., Russell, N., Sheerin, N. S., Wilson, C. H., & White, S. A. (2026). Locus-specific HLA matching and induction therapy in simultaneous pancreas–kidney transplantation: a national UK cohort study. Transplant International. https://doi.org/10.3389/ti.2026.16427
Vancouver
Malik AK, Banks J, Counter C, Simmonds L, Tingle SJ, Sinha S, et al. Locus-specific HLA matching and induction therapy in simultaneous pancreas–kidney transplantation: a national UK cohort study. Transplant International. 2026. doi:10.3389/ti.2026.16427
BibTeX
@article{Malik2026,
author = {Malik, Abdullah K and Banks, Jenni and Counter, Claire and Simmonds, Lewis and Tingle, Samuel J and Sinha, Sanjay and Muthasamy, Anand and Sutherland, Andrew and Casey, John and Drage, Martin and van Dellen, David and Callaghan, Chris J and Elker, Doruk and Manas, Derek M and Pettigrew, Gavin J and Russell, Neil and Sheerin, Neil S and Wilson, Colin H and White, Steven A},
title = {Locus-specific HLA matching and induction therapy in simultaneous pancreas–kidney transplantation: a national UK cohort study},
journal = {Transplant International},
year = {2026},
doi = {10.3389/ti.2026.16427}
}
EUVIMED